Quinidine
Showing 1 - 25 of 101
Short-coupled Idiopathic Ventricular Fibrillation Trial in Amsterdam (Quinidine, Verapamil)
Recruiting
- Short-coupled Idiopathic Ventricular Fibrillation
- Quinidine
- Verapamil
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Oct 24, 2022
Huntington Disease, Irritability Trial in Houston (Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg), Placebo)
Recruiting
- Huntington Disease
- Irritability
- Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)
- Placebo
-
Houston, TexasThe University of Texas Health Science Center at Houston
Feb 21, 2022
Hepatitis B Trial in Lenexa (EDP-514, Itraconazole, Carbamazepin)
Completed
- Hepatitis B
- EDP-514
- +3 more
-
Lenexa, KansasPharmaceutical Research Association
Aug 13, 2021
Drug-drug Interaction Trial in Melbourne (AVP-786, Paroxetine, Duloxetine)
Completed
- Drug-drug Interaction
- AVP-786
- +2 more
-
Melbourne, Victoria, AustraliaNucleus Network
Feb 15, 2022
Amyotrophic Lateral Sclerosis Trial in Fort Lauderdale, Gainesville (dextromethorphan HBr and quinidine sulfate)
Completed
- Amyotrophic Lateral Sclerosis
- dextromethorphan HBr and quinidine sulfate
-
Fort Lauderdale, Florida
- +1 more
Nov 23, 2021
Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)
Arrhythmia Trial in Worldwide (quinidine, no therapy)
Withdrawn
- Arrhythmia
- quinidine
- no therapy
-
Wynnewood, Pennsylvania
- +5 more
Feb 12, 2020
Disinhibition Syndrome Trial in Las Vegas (AVP-786, Placebo)
Terminated
- Disinhibition Syndrome
- AVP-786
- Placebo
-
Las Vegas, NevadaCleveland Clinic Lou Ruvo Center for Brain Health
Oct 1, 2020
Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786, Placebo)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- AVP-786
- Placebo
-
Phoenix, Arizona
- +73 more
Jul 22, 2022
Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786, Placebo)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- AVP-786
- Placebo
-
Birmingham, Alabama
- +82 more
Aug 23, 2022
Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (Placebo, AVP-786)
Recruiting
- Agitation in Patients With Dementia of the Alzheimer's Type
- Placebo
- AVP-786
-
Chandler, Arizona
- +158 more
Aug 23, 2022
Alzheimer's Disease, Pseudobulbar Affect (PBA) Trial in Phoenix (Nuedexta (20/10))
Terminated
- Alzheimer's Disease
- Pseudobulbar Affect (PBA)
- Nuedexta (20/10)
-
Phoenix, ArizonaBarrow Neurological Institute
Oct 25, 2019
RSV Infection Trial in Lenexa (EDP-938, Itraconazole, Rifampin)
Completed
- RSV Infection
- EDP-938
- +3 more
-
Lenexa, KansasPharmaceutical Research Associates, Inc.,
Jun 12, 2019
Healthy Trial in Dallas (Lenalidomide, Quinidine, Temsirolimus)
Completed
- Healthy
- Lenalidomide
- +3 more
-
Dallas, TexasCovance Clinical Research Unit Dallas
Nov 6, 2019
Malaria Trial in Kisumu (Artesunate, Malarone)
Completed
- Malaria
-
Kisumu, New Nyanza, KenyaNew Nyanza Provincial Hospital
Sep 20, 2019
Covid19, Amyotrophic Lateral Sclerosis Trial in Charlotte
Recruiting
- Covid19
- Amyotrophic Lateral Sclerosis
-
Charlotte, North CarolinaNeurosciences Institute, Neurology - Charlotte
Jan 24, 2023
MDD Trial in Bhubaneswar (Selective Serotonin Reuptake Inhibitors, Dextromethorphan, Placebo)
Recruiting
- Major Depressive Disorder
- Selective Serotonin Reuptake Inhibitors
- +2 more
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Feb 11, 2022
NASH - Nonalcoholic Steatohepatitis Trial in Salt Lake City (Fluconazole, Quinidine, EDP-305)
Completed
- NASH - Nonalcoholic Steatohepatitis
- Fluconazole
- +2 more
-
Salt Lake City, UtahPharmaceutical Research Associates, Inc.,
Dec 4, 2018
Safety Issues Trial in Shanghai (Nirmatrelvir and ritonavir stage 1, Nirmatrelvir and ritonavir stage 2)
Completed
- Safety Issues
- Nirmatrelvir and ritonavir stage 1
- Nirmatrelvir and ritonavir stage 2
-
Shanghai, Shanghai, ChinaDepartment of Nephrology, Renji Hospital, Shanghai JiaoTong Univ
Jun 12, 2022
Central Neuropathic Pain, Multiple Sclerosis Trial in Worldwide (AVP-923-45, AVP-923-30, AVP-923-20)
Completed
- Central Neuropathic Pain
- Multiple Sclerosis
- AVP-923-45
- +3 more
-
Cullman, Alabama
- +71 more
Oct 22, 2021
Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Clarithromycin, Pimozide, Placebo (Part 1))
Not yet recruiting
- Drug-induced QT Prolongation
- +2 more
- Clarithromycin
- +6 more
-
West Bend, WisconsinSpaulding Clinical Research
Feb 7, 2023